Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IMCD:AEX since
announced
Transaction
value
Apus Quimica SpAAnnounced30 Jun 202530 Jun 2025Announced-2.94%--
Trichem Healthcare Pvt LtdDeal completed26 Jun 202526 Jun 2025Deal completed0.04%--
Ferrer Alimentacion SAAnnounced06 Jun 202506 Jun 2025Announced-3.81%--
Medir Ferrer y Cia SAAnnounced06 Jun 202506 Jun 2025Announced-3.81%--
Tecom Ingredients SLAnnounced16 May 202516 May 2025Announced-9.68%--
Data delayed at least 15 minutes, as of Jul 18 2025 16:35 BST.

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Causeway Capital Management LLCas of 02 Jul 202519.09k0.02%
RhumbLine Advisers LPas of 31 Mar 20252.44k0.00%
Yorktown Management & Research Co., Inc.as of 31 May 20252.30k0.00%
NBC Securities, Inc.as of 30 Jun 202552.000.00%
PNC Investments LLCas of 31 Mar 202511.000.00%
Cambria Investment Management LPas of 02 Jul 20254.000.00%
GAMMA Investing LLCas of 31 Mar 20250.000.00%
More ▼
Data from 31 Mar 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.